kukumaster
commented on
I started trading only since Nov21, as I don't have a good lump sum of money to invest.
so what I did was to know what's my objective and what kind of trader am I going for.
Currently, my stocks aren't going well but I trust is a good start for a newbie for me.
what I have learnt, do not get carried off by your emotions.
Invest using your spare cash and dont investing blindly.
Stop whining and don't get embarrassed to be holding a stocks that is going down.
so what I did was to know what's my objective and what kind of trader am I going for.
Currently, my stocks aren't going well but I trust is a good start for a newbie for me.
what I have learnt, do not get carried off by your emotions.
Invest using your spare cash and dont investing blindly.
Stop whining and don't get embarrassed to be holding a stocks that is going down.
1
I'm a total greenhorn here! Most importantly, know what you want,stick to your goals.
Don't ride with emotions.
hooya!
Don't ride with emotions.
hooya!
1
kukumaster
liked
kukumaster
liked
$AbbVie (ABBV.US)$ On Oct. 7, AbbVie said top-line results showed Rinvoq (Upadacitinib) met the primary endpoint of two studies that were part of a Phase III SELect-Axis 2 trial testing its oral JAK inhibitor in patients with axial spinal arthritis. Rinvoq is already approved for rheumatoid arthritis in the United States and Europe, and the company has been looking to add more indications to its label and recently filed for use in ulcerative colitis, although the FDA has delayed some decisions as it reviews some safety issues involving JAK inhibitors.
6
kukumaster pamelo : what kind of announcements?